RightFit
Not yet recruitingPhase not listed

Together-Breast Cancer Support Platform

"Together": A Bilingual Online Platform Support Intervention Project for Korean Breast Cancer Survivors

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 12 weeks
  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks."
  • "Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes."
  • "Participants will complete surveys at baseline, mid-intervention (weeks 4-5), and post-intervention (weeks 12-13), with an optional follow-up survey at 6 months."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests an online support program made for Korean-speaking adults with breast cancer and survivors. Over 12 weeks, survivors will support patients who are getting treatment. Researchers will study how well people like and keep using the program, and whether it improves daily life, emotional health, and feelings of support.

The goal of this study is to evaluate the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors. The main questions it aims to answer are: 1) Is the peer-support program acceptable and sustainable in terms of engagement between mentors and mentees over a 12-week period? 2) Does participation in the program improve quality of life, psychological well-being (including anxiety and depression), and perceived social support? Participants will include Korean speaking breast cancer survivors (mentors) and patients currently undergoing treatment (mentees). After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks. Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Everyone must be age 18 or older and identify as Korean.
  • Everyone must read, write, and speak Korean. Mentors must also read, write, and speak English.
  • Mentors must have been diagnosed with breast cancer at least 2 years before joining.
  • Mentors must have finished active treatment or be on long-term treatment to keep the cancer under control.
  • Patients receiving support must have breast cancer and be getting treatment, such as chemotherapy, radiation, recent surgery, or hormone therapy.
  • Everyone must have a smartphone, computer, or similar device that works with the study website.
  • Everyone must agree to take part for at least 3 months and complete the required surveys.
  • Mentors must also complete the required training.

Who can't join

  • People who do not meet the requirements for joining.
  • People who cannot use the online program or needed technology.
  • People the study team decides cannot follow study steps or are not a good fit for the study.
  • Patients receiving support who have ductal carcinoma in situ (DCIS), which means abnormal cells inside the breast’s milk ducts that have not spread outside the ducts.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: Mentors: * Age ≥ 18 years * Self-identify as Korean * Able to read, write, and speak both Korean and English * Diagnosed with breast cancer ≥ 2 years prior to enrollment * Completed active treatment or currently on long-term maintenance therapy * Access to a smartphone, computer, or similar device compatible with the study platform * Willing to participate for at least 3 months * Willing to complete required training and surveys Mentees: * Age ≥ 18 years * Self-identify as Korean * Able to read, write, and speak Korean * Diagnosed with breast cancer * Currently receiving treatment (e.g., chemotherapy, radiation therapy, recent surgery, or endocrine therapy) * Access to a smartphone, computer, or similar device compatible with the study platform * Willing to participate for at least 3 months * Willing to complete required surveys Exclusion Criteria: * Individuals who do not meet the inclusion criteria * Individuals unable to use the online platform or required technology * Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures) * Mentees diagnosed with ductal carcinoma in situ (DCIS)

Study sites (1)

CA